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NEPHROTIC SYNDROME ASSOCIATED WITH TOXOPLASMOSIS. REPORT OF SEVEN CASES
Julio TOPOROVSKI(1), Simone ROMANO(1), Suzana HARTMANN(1), Wanda BENINI(1) & Pedro Paulo CHIEFFI(2,3)
SUMMARY
The concomitance of nephrotic syndrome and acute infection by Toxoplasma gondii is a rare occurrence in humans. In this paper 
seven cases of children, ranging from 11 months to 7 year-old, with concomitant nephrotic syndrome and asymptomatic acute T. gondii 
infection are reported. In one of those patients only the administration of anti-Toxoplasma therapy was enough to control the clinical and 
laboratory manifestations of the disease. In the other patients it was necessary to introduce corticosteroids or other immunosuppressant 
drugs. Three patients had complete clinical and laboratory improvement and the remaining showed only a partial response.
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INTRODUCTION
Nephrotic syndrome (NS) is mainly characterized by significant 
proteinuria, defined in children by values larger than either 40mg/
m2/h or 50 mg/kg/day and serum albumin equal or less than 2.5g%. 
The whole picture includes edema, hypercholesterolemia, and urinary 
excretion of lipids. In childhood NS is primary or idiopathic in 80-90% 
of cases; however, NS may be secondary when due to systemic diseases 
like diabetes or cancer, immune or infectious disorders, besides drug 
use. Among the infectious causes, in this paper, the association with 
toxoplasmosis will be highlighted.
Toxoplasma gondii, protozoan agent of toxoplasmosis, belongs to 
the phylum Apicomplexa and family Sarcocystidae. Although capable 
of infecting many vertebrate species, both wild and domestic cats are its 
definitive hosts, also known as complete hosts, because they allow the 
parasite´s full development. Other susceptible hosts, including humans, 
are considered incomplete hosts, in which the Toxoplasma´s life cycle 
develops only partially.
Infection with T. gondii can assume serious aspects when it occurs 
either in the congenital form or in immunosuppressed patients10. In 
immunocompetent individuals, when transmission occurs after birth, 
toxoplasmosis commonly has asymptomatic or oligosymptomatic 
courses. Several forms of presentation are known, with development 
of variable clinical manifestations; however, renal involvement with 
glomerulonephritis or nephritic syndrome is a rare event in patients 
infected with T. gondii2,4,7,9,12,13,14,21.
Due to the high frequency of toxoplasmic infection it is mandatory in 
our department to perform anti-Toxoplasma antibody tests in all children 
with nephrotic syndrome. The aim of this study is to report the clinical, 
laboratorial, therapeutic, and evolutive aspects of children who had 
concomitant nephrotic syndrome and T. gondii infection.
CLINICAL MATERIAL
A survey of medical records of outpatients who were diagnosed with 
nephrotic syndrome and, concomitantly, positivity for IgM antibodies to 
Toxoplasma, in the Pediatric Nephrology of Santa Casa de Misericórdia 
de São Paulo was conducted. In the period from 1999 to 2010 seven cases 
had been found; four were males and three females.
The initial clinical picture was the presence of edema and proteinuria. 
None of the patients showed specific symptoms for toxoplasmosis, 
such as fever or lymphadenopathy. The detection of IgM and IgG anti-
Toxoplasma antibodies was performed by enzyme linked immunosorbent 
assay (ELISA). In six cases renal biopsies had been performed.
Almost all patients were submitted to the following biochemical tests: 
total cholesterol, serum urea and creatinine, and protein in urine of 24 
hours. In only one patient, due to lack of sphincter control, proteinuria 
was assessed by the protein and creatinine ratio in a unique urine sample. 
Results of laboratory tests are shown in the Table 1.
All patients received initially anti-toxoplasmosis treatment: 
sulfadiazine (100 mg/kg/day), pyrimethamine (1 mg/kg/day) and folinic 
acid (10 mg/day), during at least one month, except those referred by 
other services, in which steroids had already been administered, receiving 
anti-Toxoplasma therapy associated to steroids. 
TOPOROVSKI, J.; ROMANO, S.; HARTMANN, S.; BENINI, W. & CHIEFFI, P.P. - Nephrotic syndrome associated with toxoplasmosis. Report of seven cases. Rev. Inst. Med. Trop. Sao 
Paulo, 54(2): 61-4, 2012.
62
The follow-up ranged from six months to nine years.
RESULTS
Case 1: Male, 2 years and 4 months old, born and raised in São 
Paulo (State of São Paulo). Presented diarrhea and vomiting without 
fever for two days; developed a cough and generalized edema. He kept 
those symptoms for 10 days, requiring hospitalization. On admission the 
patient showed regular general conditions, pallor (++/4+), with lower 
extremity edema (+/4+) without changes in other systems. 
The patient remained hospitalized for 15 days, receiving during 14 
days antibiotics and diuretics, and also starting specific treatment for 
toxoplasmosis, continued for one month. He evolved with normalization 
of proteinuria and serum albumin level, responding to the specific schema 
for toxoplasmosis. It was not necessary to introduce either steroids or 
other drugs routinely used in the treatment of nephrotic syndrome. 
Accompanied for six months the patient did not show any recurrence. Due 
to the favorable evolution the patient was not submitted to renal biopsy.
Case 2: Female, 11 months, born and raised in Barueri (State of São 
Paulo), presented with generalized edema, cough and wheeze, which was 
maintained for 15 days and she was then hospitalized. On admission 
the patient was in regular conditions; pale (++/4+). Cardiovascular and 
respiratory apparatus without changes; abdomen with ascites; showed 
edema of the abdominal wall and lower limbs (+/4+). 
The patient was submitted to treatment for toxoplasmosis with 
sulfadiazine and pyrimethamine for 20 days developing megaloblastic 
anemia; then, 10 mg of folinic acid was intravenously administered 
during five days. After spiramycin (3 g/day) was introduced for 40 days. 
Two months after, still without remission, the patient was submitted 
to renal biopsy, revealing mesangial proliferative glomerulonephritis, 
with negative immunofluorescence. She received, then, pulse therapy 
with methylprednisolone (30 mg/kg/day, maximum 1g), eight doses 
on alternate days, followed by prednisone (35 mg/m2) every other 
day. Sulfadiazine, pyrimethamine and folinic acid for one month were 
reintroduced, observing standards of proteinuria and serum albumin 
levels. Over the next six months the dosage of corticosteroids was 
gradually reduced and after seven years of follow-up the patient remains 
in complete remission.
Case 3: Male, 4 year-old, began to experience morning swelling of 
both eyelids, after the lower limbs were also affected. Laboratory tests 
confirmed a case of nephrotic syndrome.
The patient was treated with sulfadiazine, pyrimethamine and 
folinic acid for one month showing partial remission of symptoms. 
The same schema was continued for one month more in addition to 
prednisone (60 mg/m2/day, for 28 days) and the patient remained in 
remission during four months. In the next 12 months the patient showed 
six episodes of relapse, accompanied by respiratory symptoms. Then, 
renal biopsy was performed revealing minimal histological injury. 
Cyclophosphamide (2.5 mg/kg/day for 60 days) was introduced with 
evidence of complete remission.
Case 4: Female, 6 year-old, born and raised in Santos (State of 
São Paulo), revealed generalized edema, oliguria, cough and fever. 
Then, she was hospitalized with a diagnosis of nephrotic syndrome 
and pneumonia; although no data related to treatment administered 
during that hospitalization was obtained. The patient was discharged 
with prescription of prednisone (1 mg/kg on alternate days). In the 
following months the patient had recurrence of edema and was referred 
to our clinic for follow-up. On admission the patient was in regular 
conditions, pale (+/4+). Cardiac and respiratory auscultations were 
unchanged; abdomen with ascites and edema of the wall; liver was 
palpable 2 cm below the right costal margin; lower extremity edema 
(++/4+); teeth in poor condition. 
The treatment was started with sulfadiazine, pyrimethamine and 
folinic acid combined with prednisone (35 mg/m2 on alternate days) for 
one month, bringing about edema regression, but maintaining proteinuria. 
The treatment for toxoplasmosis was maintained for another month, 
raising the dose of prednisone to 60 mg/m2 daily, resulting in total 
remission of the symptoms. In the following six months recurrence 
occurred and the patient underwent pulse therapy with methyl-
prednisolone (30 mg/kg/day), eight doses on alternate days, with clinical 
improvement. The patient was submitted to a renal biopsy showing focal 
segmental glomerulosclerosis, with negative immunofluorescence. In the 
following months the dose of corticosteroids was gradually reduced until 
its suspension. The follow-up after nine years revealed that the patient 
remained in complete remission, although non-nephrotic proteinuria 
persisted, requiring treatment.
Table 1
Clinical, laboratorial and evolutive aspects of seven patients with concomitant nephrotic syndrome and asymptomatic Toxoplasma gondii infection
Patient 1 2 3 4 5 6 7
Sexa/Ageb M/2y F/11m M/4y F/6y F/7y F/7y M/20m
Albumin (g%) 1.63 1.20 1.80 1.20 1.70 2.20 2.00
Cholesterol (mg%) 227 645 390 650 350 343 388
Proteinuria (mg/Kg/day) 130 78 97 150 265 80 2.02c
Renal biopsyd Nd MPGN MCD FSGS MCD FSGS MCD
Serological testse Negative Negative Negative Negative Negative Negative Negative
Anti-Toxoplasma antibodies IgM/IgG+ IgM/IgG+ IgM/IgG+ IgM/IgG+ IgM/IgG+ IgM/IgG+ IgM+
Remission Complete Complete Complete Complete Partial Partial Partial
a - M-male; F-female; b - m-months; y-years; c - protein/creatinine ratio; d - nd-not done; MPGN-mesangial proliferative glomerulonephritis; MCD-minimal histologi-
cal injury; FSGS-focal segmental glomerulosclerosis; e - performed tests for CMV, rubella and syphilis.
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Case 5: Male, 7 year-old, presenting generalized edema. The patient 
was treated with sulfadiazine, pyrimethamine and folinic acid for one 
month and prednisone (60 mg/m2) daily for four weeks with no response. 
Because of this, the patient underwent renal biopsy which showed 
minimal histological injury, with positive immunofluorescence for IgM 
and C3. Then, the patient received seven doses of methylprednisolone 
(30 mg/kg/day) on alternate days, combined with cyclosphosphamide 
(2.5 mg/kg/day, total 92 doses) maintaining nephrotic proteinuria 
(290 mg/kg/day). Later on it was introduced cyclosporine (4 mg/kg/
day for eight months) and the patient showed a clinical and laboratory 
improvement (proteinuria: 35 mg/kg/day; albumin: 2.7 g%). He 
then received mycophenolate mofetil (500 mg/m2, over 15 months) 
showing a partial remission. Due to the development of cataract and 
pancreatitis the administration of mycophenolate and pulse therapy with 
methylprednisolone was discontinued. Vincristine was, then, introduced 
(four week doses of 1 mg/m2, followed by four monthly doses of 
1.5 mg/m2) and the patient evolved with clinical improvement. Then, the 
administration of levamisole (2.5 mg/kg/day) started on alternate days, 
continuing the administration of prednisone. After two years the patient 
remained with nephrotic proteinuria of 75 mg/kg/day and 2.7 g% of 
serum albumin without clinical decompensation.
Case 6: Female, 7 year-old, had generalized edema with frothy 
urine one week in June 2009 and was referred to the clinic of pediatric 
nephrology. At the first visit the patient was in good general condition, 
with both eyelids edema (+/4+), abdomen with ascites and edema of the 
lower limbs (++/4+). 
The treatment was started with prednisone (60 mg/m2, daily) for 
six weeks, combined with sulfadiazine, pyrimethamine and folinic 
acid, without any clinical and laboratory improvement. After, renal 
biopsy focal segmental glomerulosclerosis was found, with positive 
immunofluorescence for IgM and C3. Then, cyclosporine (4 mg/kg/
day) was introduced plus prednisone (35 mg/m2) in alternate days. After 
three months the patient progressed with partial remission (proteinuria: 
120 mg and serum albumin 3.4 g%). Administration of cyclosporine 
and prednisone was maintained and after the follow-up of 12 months 
the patient remained in partial remission, with normal albumin and 
non-nephrotic proteinuria.
Case 7: Male, one year and eight months old, was diagnosed with 
nephrotic syndrome with positive serology (IgM) for toxoplasmosis in 
another hospital, being treated with methylprednisolone pulse therapy 
(six doses), combined with anti-Toxoplasma therapy for one month. Due 
to the absence of clinical and laboratory improvement the patient was 
referred to our service.
The patient was again subjected to pulse therapy with 
methylprednisolone (six doses on alternate days) maintaining proteinuria 
and hypoalbuminemia. He was submitted to renal biopsy showing 
minimal histological lesions, with negative immunofluorescence. 
Cyclosporine (4 mg/kg/day) plus prednisone (35 mg/m2) on 
alternate days was, then, introduced, resulting in partial remission 
(normalization of serum albumin level and non-nephrotic proteinuria) after 
six months.
The clinical and laboratorial data are summarized in the Table 1.
DISCUSSION
In patients with clinical diagnosis of nephrotic syndrome it is 
mandatory to proceed to the investigation of secondary causes of disease. 
There are reports of association of nephrotic syndrome and infection by 
Toxoplasma gondii in humans, although the cause-effect relationship has 
not been fully established.
In fact, reports of nephrotic syndrome associated with toxoplasmosis 
are very scarce and, generally, those are patients with the congenital form 
of toxoplasmosis2. However, the occurrence of nephrotic syndrome in 
an adult immunocompetent woman after infection with T. gondii has 
already been reported10.
Human infection by T. gondii has a worldwide distribution and 
generally high frequency. Recent seroepidemiological surveys performed 
in different segments of the Brazilian population revealed infection rates 
ranging from 32.4 to 74.5%, depending on the age, with highest values 
occurring in adults3,16,17,18. In other countries high rates of human infection 
with T. gondii can also be found1,6,8,11,15.
The main renal diseases associated with parasitic infections are 
mesangioproliferative glomerulonephritis or tubular necrosis; minimal-
change disease or focal segmental glomerulosclerosis are found more 
rarely19,20. The majority of reports about renal lesions associated 
with toxoplasmosis refer to acute renal failure due to the deposition 
of sulfadiazine crystals in the urinary tract after treatment with this 
drug20. However, the mechanisms of renal injury in the association of 
nephrotic syndrome and toxoplasmosis are not well understood. HULDT 
(1971)5 experimentally demonstrated renal lesion with the deposition of 
immunoglobulin and immune complexes in glomeruli of mice infected 
with a low virulence T. gondii strain. Similar experiments in rabbits 
showed the same results. The histological picture found in human cases 
ranges from minimal histological injury to focal glomerulosclerosis14, a 
pattern similar to that observed in our patients.
The seven patients included in this report had an acute infection by 
T. gondii, serologically diagnosed, without clinical manifestations of the 
disease. Because of the simultaneous occurrence of nephrotic syndrome 
they were submitted to specific treatment for toxoplasmosis, the complete 
remission of the clinical and laboratory manifestations resulting in one 
of them (case 1) without using steroids or other immunosuppressant 
drugs. In the other patients it was necessary to introduce treatment for 
the nephrotic syndrome besides the anti-Toxoplasma therapy. In three 
patients a favorable response was observed and in the other three only a 
partial remission of the clinical manifestations occurred.
The data obtained from the observation of these seven patients support 
the need to investigate the possible occurrence of an acute infection by 
T. gondii in individuals who develop nephrotic syndrome without any 
previous history of kidney disease, especially when it comes to children. 
RESUMO
Síndrome nefrótica associada à toxoplasmose. Relato de sete casos.
Ocorrência concomitante de síndrome nefrótica e infecção aguda 
por Toxoplasma gondii em seres humanos é situação pouco frequente. 
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No presente trabalho são relatados sete casos de crianças, com idade 
variável entre 11 meses e sete anos, que apresentavam síndrome nefrótica 
e infecção aguda por T. gondii assintomática. Em um dos pacientes o 
tratamento específico anti-Toxoplasma foi suficiente para controlar clínica 
e laboratorialmente as manifestações da doença. Nos demais foi preciso 
administrar corticosteróides ou outras drogas imunossupressoras. Após 
introdução desse esquema três pacientes apresentaram remissão completa 
dos sintomas; os demais apenas remissão parcial.
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